contact us terms and disclaimers
links
  •  
  • investor information
  •  
  • products
  •  
  • science
  •  
  • company
  •  
  • home
  •  


  • Oct 2011 Canyon Pharmaceuticals Hono...
    Aug 2011 DESIRABLE STUDY COMPLETED...
    May 2011 Study Finds Desirudin Super...
    Jun 2010 Canyon relocates Corporate ...
    Apr 15 2010 COMPARATIVE TRIAL OF CANYON...

    About Us

    Investor Relations

    Product Information

    © Canyon Pharmaceuticals Group